0 XP   0   0   0

AVROBIO Inc










Financial Health of Avrobio




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


AVROBIO Inc
Buy, Hold or Sell?

Should you buy, hold or sell Avrobio?

I guess you are interested in AVROBIO Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Avrobio

Let's start. I'm going to help you getting a better view of AVROBIO Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is AVROBIO Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how AVROBIO Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value AVROBIO Inc. The closing price on 2022-12-02 was $0.8721 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
AVROBIO Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of AVROBIO Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avrobio earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AVROBIO Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient Avrobio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • -40.8% Return on Assets means that Avrobio generated $-0.41 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AVROBIO Inc:

  • The MRQ is -40.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.8%TTM-22.7%-18.1%
TTM-22.7%YOY-12.4%-10.3%
TTM-22.7%5Y-18.8%-3.9%
5Y-18.8%10Y-27.8%+9.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.8%-9.9%-30.9%
TTM-22.7%-8.9%-13.8%
YOY-12.4%-9.3%-3.1%
5Y-18.8%-11.7%-7.1%
10Y-27.8%-12.7%-15.1%
1.1.3. Return on Equity

Shows how efficient Avrobio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • -53.8% Return on Equity means Avrobio generated $-0.54 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AVROBIO Inc:

  • The MRQ is -53.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-53.8%TTM-28.8%-25.1%
TTM-28.8%YOY-13.4%-15.3%
TTM-28.8%5Y-15.3%-13.4%
5Y-15.3%10Y-25.6%+10.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-53.8%-12.0%-41.8%
TTM-28.8%-11.5%-17.3%
YOY-13.4%-10.8%-2.6%
5Y-15.3%-14.2%-1.1%
10Y-25.6%-15.2%-10.4%

1.2. Operating Efficiency of AVROBIO Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avrobio is operating .

  • Measures how much profit Avrobio makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AVROBIO Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y--537.1%+537.1%
1.2.2. Operating Ratio

Measures how efficient Avrobio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AVROBIO Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y-6.371-6.371

1.3. Liquidity of AVROBIO Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avrobio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.80 means the company has $7.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AVROBIO Inc:

  • The MRQ is 7.796. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.790. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.796TTM9.790-1.994
TTM9.790YOY14.526-4.736
TTM9.7905Y13.494-3.704
5Y13.49410Y11.496+1.998
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7965.117+2.679
TTM9.7905.755+4.035
YOY14.5265.854+8.672
5Y13.4946.511+6.983
10Y11.4966.222+5.274
1.3.2. Quick Ratio

Measures if Avrobio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • A Quick Ratio of 7.16 means the company can pay off $7.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AVROBIO Inc:

  • The MRQ is 7.162. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.318. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.162TTM9.318-2.156
TTM9.318YOY14.174-4.856
TTM9.3185Y13.137-3.819
5Y13.13710Y10.948+2.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1624.284+2.878
TTM9.3184.664+4.654
YOY14.1744.787+9.387
5Y13.1375.218+7.919
10Y10.9485.182+5.766

1.4. Solvency of AVROBIO Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avrobio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avrobio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24 means that Avrobio assets are financed with 24.3% credit (debt) and the remaining percentage (100% - 24.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AVROBIO Inc:

  • The MRQ is 0.243. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.196. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.243TTM0.196+0.046
TTM0.196YOY0.073+0.123
TTM0.1965Y0.310-0.113
5Y0.31010Y0.288+0.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2430.278-0.035
TTM0.1960.277-0.081
YOY0.0730.306-0.233
5Y0.3100.367-0.057
10Y0.2880.403-0.115
1.4.2. Debt to Equity Ratio

Measures if Avrobio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avrobio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 32.0% means that company has $0.32 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AVROBIO Inc:

  • The MRQ is 0.320. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.246. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.320TTM0.246+0.074
TTM0.246YOY0.079+0.166
TTM0.2465Y0.110+0.136
5Y0.11010Y0.119-0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3200.315+0.005
TTM0.2460.317-0.071
YOY0.0790.319-0.240
5Y0.1100.403-0.293
10Y0.1190.462-0.343

2. Market Valuation of AVROBIO Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avrobio generates.

  • Above 15 is considered overpriced but always compare Avrobio to the Biotechnology industry mean.
  • A PE ratio of -0.53 means the investor is paying $-0.53 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AVROBIO Inc:

  • The EOD is -0.723. Company is losing money. -2
  • The MRQ is -0.531. Company is losing money. -2
  • The TTM is -2.468. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.723MRQ-0.531-0.192
MRQ-0.531TTM-2.468+1.938
TTM-2.468YOY-15.558+13.089
TTM-2.4685Y-33.820+31.351
5Y-33.82010Y-28.183-5.637
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.723-8.986+8.263
MRQ-0.531-9.792+9.261
TTM-2.468-16.243+13.775
YOY-15.558-20.876+5.318
5Y-33.820-16.665-17.155
10Y-28.183-14.732-13.451
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Avrobio.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of AVROBIO Inc:

  • The MRQ is 1.132. Seems overpriced? -1
  • The TTM is -5.988. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ1.132TTM-5.988+7.120
TTM-5.988YOY-58.874+52.886
TTM-5.9885Y3,350.598-3,356.586
5Y3,350.59810Y3,350.5980.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.132-0.032+1.164
TTM-5.9880.004-5.992
YOY-58.8740.016-58.890
5Y3,350.5980.006+3,350.592
10Y3,350.5980.003+3,350.595

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avrobio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.29 means the investor is paying $0.29 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AVROBIO Inc:

  • The EOD is 0.389. Very good. +2
  • The MRQ is 0.286. Very good. +2
  • The TTM is 0.506. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.389MRQ0.286+0.104
MRQ0.286TTM0.506-0.220
TTM0.506YOY1.952-1.446
TTM0.5065Y3.691-3.185
5Y3.69110Y3.076+0.615
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3891.835-1.446
MRQ0.2862.006-1.720
TTM0.5062.774-2.268
YOY1.9523.453-1.501
5Y3.6912.713+0.978
10Y3.0762.402+0.674
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of AVROBIO Inc.

3.1. Institutions holding AVROBIO Inc

Institutions are holding 62.186% of the shares of AVROBIO Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30GMT Capital Corp7.9830.2044349449089957634.6669
2022-06-30JPMorgan Chase & Co4.84320.000321200441256536.3003
2022-06-30Renaissance Technologies Corp3.55420.0017155580067070075.7767
2022-06-30Acadian Asset Management LLC2.56670.0053112356411235640
2022-06-30K2 PRINCIPAL FUND LP2.54760.1132111517711151770
2022-06-30Vanguard Group Inc2.331301020487-52681-4.9089
2022-09-30Aisling Capital Management LP2.30680.429100977900
2022-06-30Millennium Management LLC1.81510.000579452227008351.4994
2022-06-30Farallon Capital Management, L.L.C.1.69050.004274000000
2022-06-30Citadel Advisors Llc1.57970.00026914807345211.8849
2022-06-30MPM Oncology Impact Management LP1.48010.165664791800
2022-06-30Two Sigma Advisers, LLC1.29760.0015568000-107800-15.9515
2022-06-30RA Capital Management, LLC1.27840.01375596005596000
2022-06-30Two Sigma Investments LLC1.0820.0014473644-198789-29.5626
2022-06-30D. E. Shaw & Co LP1.02540.0005448844-32407-6.7339
2022-06-30Geode Capital Management, LLC0.88380.0001386858-358823-48.1202
2022-06-30GSA Capital Partners LLP0.75450.0456330281-8141-2.4056
2022-06-30New Leaf Venture Partners, L.L.C.0.72090.187931555000
2022-06-30Goldman Sachs Group Inc0.33910148446-123303-45.3739
2022-06-30State Street Corporation0.32180140852-484959-77.4929
Total 40.40171.175117685336+3470902+19.6%

3.2. Funds holding AVROBIO Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-10-31Vanguard Total Stock Mkt Idx Inv1.4405063057900
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr1.4405063057913682727.7117
2022-10-31Vanguard Extended Market Index Investor1.17340.000451366100
2022-03-31BlackRock Advantage Small Cap Core Instl1.09450.014847912700
2022-10-31iShares Biotechnology ETF0.64610.002428280313560.4818
2022-09-30Fidelity® Extended Market Index0.52110.000522812500
2022-06-30Bridgeway Ultra-Small Company Market0.28560.0605125000-98100-43.9713
2022-09-30Blackrock Russell 2000 Alpha Tilts Fd A0.20820.008291122-6660-6.8111
2022-10-31iShares Micro-Cap ETF0.19230.00638419900
2022-06-30BlackRock Extended Mkt Composite0.1870.000681871818710
2022-09-30BlackRock Extended Equity Market K0.16510.000572287-666-0.9129
2022-09-30Spartan Total Market Index Pool E0.14120.00026179500
2022-06-30Perinvest(Lux) Sicav Glb Hlthcare Eq B0.12820.67835610000
2022-03-31iShares Russell 2000 Small-Cap Idx Instl0.11970.00165237600
2022-09-30Fidelity® Total Market Index0.10960.00014795900
2022-10-31iShares Core S&P Total US Stock Mkt ETF0.10810.00014732700
2022-09-30Fidelity® Series Total Market Index0.09630.00014214100
2022-09-30Schwab Total Stock Market Index0.08510.00023723100
2022-09-30DWS Biotech LC0.080.00593500100
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.07070.00043096800
Total 8.29320.78113630251+114628+3.2%

3.3. Insider Transactions

Insiders are holding 2.678% of the shares of AVROBIO Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800
2021-07-07Philip J. VickersBUY48008.354800

4. Summary

4.1. Key Performance Indicators

The key performance indicators of AVROBIO Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.463-0.545+18%-0.082-82%0.107-532%0.093-596%
Book Value Growth---0.206-0.186-10%-0.026-87%0.001-24753%0.001-28451%
Book Value Per Share--2.2413.022-26%5.151-56%3.616-38%3.030-26%
Book Value Per Share Growth---0.206-0.186-10%-0.026-87%0.001-24753%0.001-28451%
Current Ratio--7.7969.790-20%14.526-46%13.494-42%11.496-32%
Debt To Asset Ratio--0.2430.196+24%0.073+232%0.310-22%0.288-16%
Debt To Equity Ratio--0.3200.246+30%0.079+303%0.110+192%0.119+169%
Dividend Per Share----0%-0%-0%-0%
Eps---1.206-0.793-34%-0.680-44%-0.552-54%-0.471-61%
Eps Growth---0.469-0.076-84%0.043-1186%-0.069-85%-0.069-85%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.389+27%0.2860.506-44%1.952-85%3.691-92%3.076-91%
Pe Ratio-0.723-36%-0.531-2.468+365%-15.558+2832%-33.820+6274%-28.183+5212%
Peg Ratio--1.132-5.988+629%-58.874+5301%3350.598-100%3350.598-100%
Price Per Share0.872+27%0.6401.683-62%10.275-94%13.175-95%10.979-94%
Price To Total Gains Ratio-1.885-36%-1.383-3.049+120%-13.579+882%-28.251+1942%-28.251+1942%
Profit Growth---46.869-7.593-84%4.317-1186%-8.474-82%-5.375-89%
Quick Ratio--7.1629.318-23%14.174-49%13.137-45%10.948-35%
Return On Assets---0.408-0.227-44%-0.124-70%-0.188-54%-0.278-32%
Return On Equity---0.538-0.288-47%-0.134-75%-0.153-72%-0.256-52%
Total Gains Per Share---0.463-0.545+18%-0.082-82%0.107-532%0.093-596%
Total Gains Per Share Growth--0.2250.085+166%-0.314+239%-0.988+538%-0.988+538%
Usd Book Value--98090000.000132268000.000-26%225458750.000-56%158289900.000-38%132645083.333-26%
Usd Book Value Change Per Share---0.463-0.545+18%-0.082-82%0.107-532%0.093-596%
Usd Book Value Per Share--2.2413.022-26%5.151-56%3.616-38%3.030-26%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.206-0.793-34%-0.680-44%-0.552-54%-0.471-61%
Usd Price Per Share0.872+27%0.6401.683-62%10.275-94%13.175-95%10.979-94%
Usd Profit---52802000.000-34729000.000-34%-29757500.000-44%-23822450.000-55%-20506875.000-61%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.463-0.545+18%-0.082-82%0.107-532%0.093-596%
 EOD+2 -3MRQTTM+8 -19YOY+4 -235Y+6 -2110Y+6 -21

4.2. Fundamental Score

Let's check the fundamental score of AVROBIO Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.723
Price to Book Ratio (EOD)Between0-10.389
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than17.162
Current Ratio (MRQ)Greater than17.796
Debt to Asset Ratio (MRQ)Less than10.243
Debt to Equity Ratio (MRQ)Less than10.320
Return on Equity (MRQ)Greater than0.15-0.538
Return on Assets (MRQ)Greater than0.05-0.408
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of AVROBIO Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.540
Ma 20Greater thanMa 500.785
Ma 50Greater thanMa 1000.709
Ma 100Greater thanMa 2000.827
OpenGreater thanClose0.900
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets129,497
Total Liabilities31,407
Total Stockholder Equity98,090
 As reported
Total Liabilities 31,407
Total Stockholder Equity+ 98,090
Total Assets = 129,497

Assets

Total Assets129,497
Total Current Assets126,233
Long-term Assets126,233
Total Current Assets
Cash And Cash Equivalents 115,968
Other Current Assets 10,265
Total Current Assets  (as reported)126,233
Total Current Assets  (calculated)126,233
+/-0
Long-term Assets
Property Plant Equipment 3,223
Long-term Assets Other 41
Long-term Assets  (as reported)3,264
Long-term Assets  (calculated)3,264
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities16,192
Long-term Liabilities15,215
Total Stockholder Equity98,090
Total Current Liabilities
Accounts payable 1,814
Other Current Liabilities 14,378
Total Current Liabilities  (as reported)16,192
Total Current Liabilities  (calculated)16,192
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)15,215
Long-term Liabilities  (calculated)0
+/- 15,215
Total Stockholder Equity
Common Stock4
Retained Earnings -464,398
Other Stockholders Equity 562,484
Total Stockholder Equity (as reported)98,090
Total Stockholder Equity (calculated)98,090
+/-0
Other
Cash and Short Term Investments 115,968
Common Stock Shares Outstanding 43,773
Liabilities and Stockholders Equity 129,497
Net Debt -115,968



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
5,400
0
0
0
7,022
60,216
158,730
143,272
133,479
117,368
101,989
217,205
200,514
269,728
255,568
233,255
271,234
245,912
238,095
216,453
203,837
175,343
146,244
129,497
129,497146,244175,343203,837216,453238,095245,912271,234233,255255,568269,728200,514217,205101,989117,368133,479143,272158,73060,2167,0220005,400
   > Total Current Assets 
5,376
0
0
0
6,308
58,481
156,147
140,078
130,020
113,679
98,188
213,707
195,701
265,347
251,020
228,986
267,242
242,064
233,519
211,658
199,145
170,921
142,081
126,233
126,233142,081170,921199,145211,658233,519242,064267,242228,986251,020265,347195,701213,70798,188113,679130,020140,078156,14758,4816,3080005,376
       Cash And Cash Equivalents 
5,357
0
0
0
5,963
57,928
155,015
138,577
126,302
108,476
90,348
206,362
187,043
257,695
244,380
219,546
259,682
233,027
226,438
201,369
189,567
161,663
132,409
115,968
115,968132,409161,663189,567201,369226,438233,027259,682219,546244,380257,695187,043206,36290,348108,476126,302138,577155,01557,9285,9630005,357
       Short-term Investments 
0
0
0
0
0
0
0
396
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003960000000
       Net Receivables 
0
0
0
0
0
0
0
0
1,545
1,468
1,712
2,120
2,140
2,183
2,139
2,366
2,562
2,739
2,332
2,662
2,697
2,844
2,960
0
02,9602,8442,6972,6622,3322,7392,5622,3662,1392,1832,1402,1201,7121,4681,54500000000
       Other Current Assets 
19
0
0
0
345
553
1,132
1,501
2,173
3,735
6,128
5,225
6,518
5,469
4,501
7,074
4,998
6,298
4,749
7,627
9,578
6,414
9,672
10,265
10,2659,6726,4149,5787,6274,7496,2984,9987,0744,5015,4696,5185,2256,1283,7352,1731,5011,13255334500019
   > Long-term Assets 
0
0
0
0
714
1,735
2,583
3,194
3,459
3,689
3,801
3,498
4,813
4,381
4,548
4,269
3,992
3,848
4,576
4,795
4,692
4,422
4,163
3,264
3,2644,1634,4224,6924,7954,5763,8483,9924,2694,5484,3814,8133,4983,8013,6893,4593,1942,5831,7357140000
       Property Plant Equipment 
0
0
0
0
349
604
2,050
2,306
2,634
2,864
2,741
2,673
3,696
3,407
3,580
3,312
3,064
2,930
3,990
4,219
4,126
3,867
3,618
3,223
3,2233,6183,8674,1264,2193,9902,9303,0643,3123,5803,4073,6962,6732,7412,8642,6342,3062,0506043490000
       Long-term Assets Other 
0
0
0
0
365
1,131
533
888
825
825
1,060
825
1,117
974
968
957
928
918
586
576
566
555
545
41
415455555665765869189289579689741,1178251,0608258258885331,1313650000
> Total Liabilities 
979
0
0
0
30,157
6,180
10,412
6,163
11,295
10,580
9,355
10,445
14,501
13,203
15,781
25,383
16,890
12,982
17,103
22,884
34,361
32,180
27,901
31,407
31,40727,90132,18034,36122,88417,10312,98216,89025,38315,78113,20314,50110,4459,35510,58011,2956,16310,4126,18030,157000979
   > Total Current Liabilities 
891
0
0
0
2,625
5,061
9,631
5,427
10,606
9,935
8,765
9,910
14,017
12,773
15,411
25,052
16,614
12,768
16,953
22,794
19,386
17,130
12,785
16,192
16,19212,78517,13019,38622,79416,95312,76816,61425,05215,41112,77314,0179,9108,7659,93510,6065,4279,6315,0612,625000891
       Accounts payable 
340
0
0
0
527
2,052
4,193
1,582
2,784
3,458
2,572
1,408
3,949
2,135
2,619
2,311
2,682
2,698
2,029
2,966
3,486
4,037
28
1,814
1,814284,0373,4862,9662,0292,6982,6822,3112,6192,1353,9491,4082,5723,4582,7841,5824,1932,052527000340
       Other Current Liabilities 
551
0
0
0
2,098
3,009
5,438
3,845
7,822
6,477
6,193
8,502
10,068
10,638
12,792
22,741
13,932
10,070
14,924
19,828
15,900
13,093
12,757
14,378
14,37812,75713,09315,90019,82814,92410,07013,93222,74112,79210,63810,0688,5026,1936,4777,8223,8455,4383,0092,098000551
   > Long-term Liabilities 
0
0
0
0
27,532
1,119
781
736
689
645
590
535
484
430
370
331
276
214
150
90
14,975
15,050
15,116
15,215
15,21515,11615,05014,975901502142763313704304845355906456897367811,11927,5320000
       Deferred Long Term Liability 
0
0
0
0
85
0
781
736
689
645
590
535
133
430
370
331
276
214
150
90
0
0
0
0
0000901502142763313704301335355906456897367810850000
> Total Stockholder Equity
4,421
-4,579
0
0
-23,135
54,036
148,318
137,109
122,184
106,788
92,634
206,760
186,013
256,525
239,787
207,872
254,344
232,930
220,992
193,569
169,476
143,163
118,343
98,090
98,090118,343143,163169,476193,569220,992232,930254,344207,872239,787256,525186,013206,76092,634106,788122,184137,109148,31854,036-23,13500-4,5794,421
   Common Stock
1
0
0
0
1
2
2
2
2
2
2
3
3
4
4
4
4
4
4
4
4
4
4
4
444444444443322222210001
   Retained Earnings Total Equity0000-355,315-322,702-291,315-264,416-236,285-199,505-170,677-144,704-122,042-104,897-88,842-71,739-55,718-44,127000000
   Accumulated Other Comprehensive Income 00000-3,011-2,7120-2,132-1,818-1,517-1,234-989-774-575-384-200-71-25-450000
   Capital Surplus 
0
0
0
0
0
0
192,443
192,825
193,921
195,628
197,529
328,799
330,714
427,198
439,288
444,153
518,756
524,241
543,690
548,880
0
0
0
0
0000548,880543,690524,241518,756444,153439,288427,198330,714328,799197,529195,628193,921192,825192,443000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
384
87,679
192,514
193,025
194,305
196,203
198,303
329,788
331,948
428,715
441,106
446,285
518,756
526,953
546,701
548,880
553,014
556,534
559,768
562,484
562,484559,768556,534553,014548,880546,701526,953518,756446,285441,106428,715331,948329,788198,303196,203194,305193,025192,51487,6793840000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-118,841
Operating Income-118,841-118,841
 
Operating Expense (+$)
Research Development83,114
Selling General Administrative35,727
Selling And Marketing Expenses-
Operating Expense118,841118,841
 
Net Interest Income (+$)
Interest Income-
Interest Expense-224
Net Interest Income-224-224
 
Pretax Income (+$)
Operating Income-118,841
Net Interest Income-224
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-119,126-118,556
EBIT - interestExpense = -119,065
-119,126
-118,902
Interest Expense224
Earnings Before Interest and Taxes (ebit)-118,841-118,902
Earnings Before Interest and Taxes (ebitda)-118,841
 
After tax Income (+$)
Income Before Tax-119,126
Tax Provision--
Net Income From Continuing Ops-119,126-119,126
Net Income-119,126
Net Income Applicable To Common Shares-119,126
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-285224
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZCL.CC
8 hours ago

I found you a Golden Cross on the daily chart of ZCL.CC.

ZCL.CC Daily Candlestick Chart
XPC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XPC.CC.

XPC.CC Daily Candlestick Chart
XNC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of XNC.CC.

XNC.CC Daily Candlestick Chart
XMY.CC
8 hours ago

I found you a Three White Soldiers Candle Pattern on the daily chart of XMY.CC.

XMY.CC Daily Candlestick Chart
XFT.CC
8 hours ago

I found you a Rising Three Methods Candle Pattern on the daily chart of XFT.CC.

XFT.CC Daily Candlestick Chart
WING.CC
8 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WING.CC.

WING.CC Daily Candlestick Chart
vUSDC.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of vUSDC.CC.

vUSDC.CC Daily Candlestick Chart
VOLLAR.CC
8 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
UUU.CC
8 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of UUU.CC.

UUU.CC Daily Candlestick Chart
UGAS.CC
8 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of UGAS.CC.

UGAS.CC Daily Candlestick Chart
UBQ.CC
8 hours ago

I found you a Death Cross on the daily chart of UBQ.CC.

UBQ.CC Daily Candlestick Chart
TRXBULL.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TRXBULL.CC.

TRXBULL.CC Daily Candlestick Chart
TH.CC
8 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of TH.CC.

TH.CC Daily Candlestick Chart
THC.CC
8 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of THC.CC.

THC.CC Daily Candlestick Chart
TEL.CC
8 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
SWG.CC
8 hours ago

I found you a Death Cross on the daily chart of SWG.CC.

SWG.CC Daily Candlestick Chart
SNC.CC
8 hours ago

I found you a Death Cross on the daily chart of SNC.CC.

SNC.CC Daily Candlestick Chart
SHROOM.CC
8 hours ago

I found you a Morning Star Candle Pattern on the daily chart of SHROOM.CC.

SHROOM.CC Daily Candlestick Chart
SATT.CC
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATT.CC.

SATT.CC Daily Candlestick Chart
RYO.CC
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RYO.CC.

RYO.CC Daily Candlestick Chart
REAP.CC
9 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of REAP.CC.

REAP.CC Daily Candlestick Chart
RBN.CC
9 hours ago

I found you a Death Cross on the daily chart of RBN.CC.

RBN.CC Daily Candlestick Chart
RAK.CC
9 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RAK.CC.

RAK.CC Daily Candlestick Chart
PLAY.CC
9 hours ago

I found you a Death Cross on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart